首页 | 本学科首页   官方微博 | 高级检索  
     


High expression of Lewisy/bantigens is associated with decreased survival in lymph node negative breast carcinomas
Authors:Zahra?Madjd,Tina?Parsons,Nicholas?FS?Watson,Ian?Spendlove,Ian?Ellis,Lindy?G?Durrant  author-information"  >  author-information__contact u-icon-before"  >  mailto:lindy.durrant@nottingham.ac.uk"   title="  lindy.durrant@nottingham.ac.uk"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author
Affiliation:(1) Academic Department of Clinical Oncology, Institute of Infections Immunity and Inflammation, University of Nottingham, City Hospital, Nottingham, UK;(2) Scancell Ltd, BioCity, Nottingham, UK;(3) Department of Histopathology, City Hospital, Nottingham, UK
Abstract:

Introduction  

There is sufficient evidence that blood group related Lewis antigens are tumour-associated molecules. The Lewisy and Lewisb antigens are complex carbohydrates that are over-expressed by breast, lung, colon and ovarian cancers. The SC101 mAb is a unique Lewisy/b binding antibody that binds to native and extended Lewisy and Lewisb haptens, displaying no cross reactivity with H type 1, H type 2, Lewisx or normal blood group antigens.
Keywords:
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号